$2.35B AmSurg Anesthesia Acquisition Deal, New Regent Surgical Health ASC & More – 5 Recent ASC Company Key Notes
AmSurg will acquire Sheridan Healthcare in a cash and stock transaction of approximately $2.35 billion. Sheridan offers services in 25 states and employs more than 2,400 physicians and healthcare providers.
Surgical Care Affiliates reported system-wide net patient revenue per case grew 5.4 percent in the first quarter of 2014. The growth is attributed to acquisitions, changes in payer contracts and case volume, according a news release.
Regent Surgical Health, a group of physicians and Providence Health & Services opened a joint venture ASC on the Providence Portland (Ore.) Medical Center campus.
Hospital Corporation of America stocks traded at $52.99 per share during the week of May 26 to 30.
Medical Facilities Corporation elected seven directors at its annual shareholders' meeting. The directors included:
• David R. Bellaire
• Marilynne Day-Linton
• Gil Faclier, MD
• Irving R. Gerstein
• John T. Perri
• Donald Schellpfeffer, MD
• Seymour Temkin
If you have a question, issue or note to suggest on an ASC management and development company please contact Carrie Pallardy at email@example.com or Laura Miller at firstname.lastname@example.org.
More Articles on ASC Issues:
4 Steps to Add Value to Established Joint Venture ASCs
Revenue Cycle Management Challenges: Best Practices for Eye Centers
3 Recently Opened & Expanded Ambulatory Surgery Centers
© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
New From Becker's ASC Review
Dr. Kevin Daneshgar performs La Peer Surgery Center's first laparoscopic hysterectomyRead Now
- Baltimore Washington Eye Center adds Alcon CENTURION Vision System
- MRidium IV infusion pump system resumes U.S. distribution
- CMS announces new ICD-10 end-to-end testing opportunity for providers
- TiGenix submits Phase III Cx601 trial design to FDA for approval
- FDA approves new hepatitis C treatment drug